Literature DB >> 27351708

Microbial Profile and Antimicrobial Susceptibility of Bacteria Found in Inflammatory Hidradenitis Suppurativa Lesions.

Schapoor Hessam1, Michael Sand, Dimitrios Georgas, Agnes Anders, Falk G Bechara.   

Abstract

BACKGROUND: The role of bacterial colonization in hidradenitis suppurativa (HS) lesions is poorly understood. To date, data on the related microbial profile and especially on bacterial resistance rates are scarce.
METHODS: The results of bacterial cultures and susceptibility patterns of the isolated microorganisms obtained from deep portions of HS lesions from patients who underwent surgery at our HS Centre between 2010 and 2015 were retrospectively evaluated.
RESULTS: Analyses of 113 bacterial samples from 113 HS patients revealed bacterial growth in 95 samples (84.1%). Polymicrobial growth was found in 51 samples (45.1%). Coagulase-negative staphylococci and Staphylococcus aureus were the most commonly isolated bacteria, followed by Proteus mirabilis and Escherichia coli. Data on susceptibility testing were available for 68 samples, which yielded 129 isolates. The isolated strains were primarily resistant to penicillin G, followed by erythromycin, clindamycin and ampicillin. The highest effectiveness against isolates was observed for fosfomycin, imipenem, fluoroquinolones (moxifloxacin, ciprofloxacin, levofloxacin), and cotrimoxazole.
CONCLUSIONS: Our findings on bacterial species and their topographical distribution revealed that the microbial flora in HS lesions reflects commensal flora of the skin. Due to the susceptibility rate and immunomodulatory and anti-inflammatory properties, cotrimoxazole may represent an alternative antibiotic agent and should be considered for therapy in HS patients.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27351708     DOI: 10.1159/000446812

Source DB:  PubMed          Journal:  Skin Pharmacol Physiol        ISSN: 1660-5527            Impact factor:   3.479


  9 in total

1.  Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.

Authors:  S Hessam; M Sand; M Skrygan; T Gambichler; F G Bechara
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

2.  [Psychiatric comorbidities in hidradenitis suppurativa/acne inversa].

Authors:  Paraskevi Mavrogiorgou; Georg Juckel; Andreas Reimelt; Schapoor Hessam; Lisa Scholl; Jessica Lisa Frajkur; Eggert Stockfleth; Falk G Bechara
Journal:  Hautarzt       Date:  2021-01-04       Impact factor: 0.751

Review 3.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

Authors:  Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal:  J Am Acad Dermatol       Date:  2019-03-11       Impact factor: 15.487

4.  A systematic review and critical appraisal of metagenomic and culture studies in hidradenitis suppurativa.

Authors:  Samuel C Williams; John W Frew; James G Krueger
Journal:  Exp Dermatol       Date:  2020-08-11       Impact factor: 4.511

5.  Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials.

Authors:  G B E Jemec; M M Okun; S B Forman; W P F Gulliver; E P Prens; U Mrowietz; A W Armstrong; Z Geng; Y Gu; D A Williams; H D Teixeira; A B Kimball
Journal:  Br J Dermatol       Date:  2019-08-14       Impact factor: 9.302

6.  Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.

Authors:  Ester Del Duca; Paola Morelli; Luigi Bennardo; Cosimo Di Raimondo; Steven Paul Nisticò
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

7.  Successful Treatment of Coexistent Acne Fulminans and Severe Hidradenitis Suppurativa with Adalimumab.

Authors:  George Kontochristopoulos; Efthymia Agiasofitou; Eftychia Platsidaki; Anastasia Kapsiocha; Stamatios Gregoriou; Dimitrios Rigopoulos
Journal:  Skin Appendage Disord       Date:  2021-03-30

8.  Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study.

Authors:  Elisa Molinelli; Valerio Brisigotti; Oriana Simonetti; Claudia Sapigni; Giovanni Marco D'Agostino; Giulio Rizzetto; Alfredo Giacchetti; Annamaria Offidani
Journal:  Dermatol Ther       Date:  2022-03-18       Impact factor: 3.858

Review 9.  The Microbiome in Hidradenitis Suppurativa: A Review.

Authors:  Kirsty J L Wark; Geoffrey D Cains
Journal:  Dermatol Ther (Heidelb)       Date:  2020-11-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.